Biased β2-adrenoceptor signalling in heart failure: pathophysiology and drug discovery-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Biased β2-adrenoceptor signalling in heart failure: pathophysiology and drug discovery

Published:2014-12-17 Issue:23 Volume:172 Page:5444-5456
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Woo Anthony Yiu-Ho¹²,Song Ying¹,Xiao Rui-Ping¹³,Zhu Weizhong⁴

Affiliation:

1. Institute of Molecular Medicine; Centre for Life Sciences; Peking University; Beijing China

2. Key Laboratory of Chemical Genomics; School of Chemical Biology and Biotechnology; Peking University Shenzhen Graduate School; Shenzhen China

3. Beijing Key Laboratory of Cardiometabolic Molecular Medicine; Peking University; Beijing China

4. Department of Pharmacology; Nantong University School of Pharmacy; Nantong China

Funder

National Basic Research Program of China

National Science and Technology Major Project of China

National Natural Science Foundation of China

National Major Scientific Research Program of China

Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Peking University

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.12965/fullpdf

Reference127 articles.

1. Beneficial effects of chronic pharmacological manipulation of beta-adrenoreceptor subtype signaling in rodent dilated ischemic cardiomyopathy;Ahmet;Circulation,2004

2. Pharmacological stimulation of beta2-adrenergic receptors (beta2AR) enhances therapeutic effectiveness of beta1AR blockade in rodent dilated ischemic cardiomyopathy;Ahmet;Heart Fail Rev,2005

3. Cardioprotective and survival benefits of long-term combined therapy with beta2 adrenoreceptor (AR) agonist and beta1 AR blocker in dilated cardiomyopathy postmyocardial infarction;Ahmet;J Pharmacol Exp Ther,2008

4. Therapeutic efficacy of a combination of a beta1-adrenoreceptor (AR) blocker and beta2-AR agonist in a rat model of postmyocardial infarction dilated heart failure exceeds that of a beta1-AR blocker plus angiotensin-converting enzyme inhibitor;Ahmet;J Pharmacol Exp Ther,2009

5. The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors;Alexander;Br J Pharmacol,2013a

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure and dynamics determine G protein coupling specificity at a class A GPCR;2024-03-29

2. Cardiac adrenergic receptors and GRKs: mitochondrial modulation in the heart;Current Opinion in Physiology;2024-02

3. Roles of β-adrenoceptor Subtypes and Therapeutics in Human Cardiovascular Disease: Heart Failure, Tachyarrhythmias and Other Cardiovascular Disorders;Handbook of Experimental Pharmacology;2024

4. The influence of low-intensity laser radiation on the blood parameters of cows under technological stress;Вестник российской сельскохозяйственной науки;2023-12-15

5. Status of β1-Adrenoceptor Signal Transduction System in Cardiac Hypertrophy and Heart Failure;Reviews in Cardiovascular Medicine;2023-09-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3